Quick Answer
MYRIAD GENETICS INC reported Research And Development Expense of $106.80 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -5.8% in Research And Development Expense from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2009 to 2025), MYRIAD GENETICS INC's Research And Development Expense has grown by 496.2%.
- Historical annual values: Fiscal year 2025: $106.80 million | Fiscal year 2024: $113.40 million | Fiscal year 2023: $88.70 million | Fiscal year 2022: $85.40 million | Fiscal year 2021: $81.90 million | Fiscal year 2020: $73.30 million | Fiscal year 2020: $77.20 million | Fiscal year 2019: $85.90 million | Fiscal year 2018: $70.80 million | Fiscal year 2017: $74.40 million | Fiscal year 2016: $70.60 million | Fiscal year 2015: $75.50 million | Fiscal year 2014: $67.50 million | Fiscal year 2013: $53.70 million | Fiscal year 2012: $42.65 million | Fiscal year 2011: $27.75 million | Fiscal year 2010: $21.87 million | Fiscal year 2009: $17.91 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: